1. Home
  2. SUNS vs RANI Comparison

SUNS vs RANI Comparison

Compare SUNS & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$7.50

Market Cap

108.7M

Sector

Real Estate

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.85

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
RANI
Founded
2023
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
106.9M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
SUNS
RANI
Price
$7.50
$0.85
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$8.75
$7.50
AVG Volume (30 Days)
78.9K
666.7K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
16.17%
N/A
EPS Growth
N/A
57.14
EPS
0.54
N/A
Revenue
$21,571,434.00
$1,633,000.00
Revenue This Year
$70.81
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
$13.96
N/A
Revenue Growth
102.96
58.85
52 Week Low
$7.34
$0.44
52 Week High
$11.78
$3.87

Technical Indicators

Market Signals
Indicator
SUNS
RANI
Relative Strength Index (RSI) 42.95 52.92
Support Level $7.38 $0.73
Resistance Level $8.04 $0.94
Average True Range (ATR) 0.20 0.05
MACD 0.00 0.00
Stochastic Oscillator 36.21 53.56

Price Performance

Historical Comparison
SUNS
RANI

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: